Aria Care Partners Acquires Precision Mobile Care of Utah
Aria Care Partners acquired Precision Mobile Care, a Utah-based mobile dental services provider serving skilled nursing communities, its third acquisition this year.
The archive
996 deals tracked since Aug 26, 2026, worth $506B in announced deal value. Every link is free to read.
Aria Care Partners acquired Precision Mobile Care, a Utah-based mobile dental services provider serving skilled nursing communities, its third acquisition this year.
LeanTaaS acquired Aidin, a care transition platform serving 200+ hospitals and coordinating over two million referrals annually, to extend its inpatient flow software.
BioMarin Pharmaceutical completed its acquisition of Alesta Therapeutics, adding oral hypophosphatasia candidate ALE1; Alesta spun out all non-ALE1 assets before closing.
RedHill Biopharma acquired exclusive commercialization rights to Ferring's Rebyota and Clenpiq for a $12 million upfront payment plus milestones and royalties, funded by its $18 million Talicia divestiture.
Black Pearl Equities completed its all-cash tender offer at $5.75 per share for Selectis Health, acquiring about 90.93% of shares and will squeeze out the remainder via merger.
Enovis Corporation entered a binding offer to acquire French surgical robotics developer eCential Robotics, with closing expected in Q4 2026 subject to works council process and regulatory approvals.
Eli Lilly signed a definitive agreement to acquire Merida Biosciences, developer of antibody-degrading biologics for autoimmune and allergic diseases, with lead candidate MER511 in Phase 1.
RedHill Biopharma agreed to sell its Talicia business to a subsidiary of Apotex Health Corp. for $18 million upfront plus up to $35 million in net sales milestone payments.
Samsung Biologics, via Swiss subsidiary Samsung Peptide AG, published its tender offer prospectus to buy all publicly held PolyPeptide shares at CHF 44.31 cash, implying ~CHF 1.46 billion equity value.
Black Pearl Equities extended its all-cash tender offer for all outstanding shares of Selectis Health at $5.75 per share to August 31, 2026.
Eli Lilly has proposed acquiring AtaiBeckley for $6.75 per share in cash plus up to $2.50 per share in contingent value rights tied to BPL-003 and VLS-01 milestones.
Healthcare payer operations firm Imagenet acquired Analytica Consulting, a California data engineering, analytics and AI consultancy.